Home / Products / Cancer (Tumor) Cell Lines / UPCI-SCC-172
UPCI-SCC-172
Datasheet Protocol

UPCI-SCC-172

Cat. No. ARC0990
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Pharynx (oropharynx)

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

UPCI-SCC-172 is a cancer cell line of pharynx (oropharynx) squamous cell carcinoma from Homo sapiens (Human).

Recommended Products

FBXL15 Knockout NCI-H1975 Polyclonal Cells FBXL15 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG17113 FAM3C Knockout jurkat Polyclonal Cells FAM3C Knockout jurkat Polyclonal Cells Cat. No. ARG12849 MTCL1 Knockout Hela Polyclonal Cells MTCL1 Knockout Hela Polyclonal Cells Cat. No. ARG7961 GPAA1 Knockout 786-O Polyclonal Cells GPAA1 Knockout 786-O Polyclonal Cells Cat. No. ARG25185 LIMD1 Knockout HEK293T Polyclonal Cells LIMD1 Knockout HEK293T Polyclonal Cells Cat. No. ARG3995 Mouse Carotid Artery Endothelial Cell Medium Mouse Carotid Artery Endothelial Cell Medium Cat. No. ARM0440
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Pharynx (oropharynx)
Disease:
Squamous cell carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
68 years
Sex of Donor:
Male
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

PARD6B Knockout NCI-H1975 Polyclonal Cells

PARD6B Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG16963
 CYP1B1 Knockout NCI-H1299 Polyclonal Cells

CYP1B1 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17979
 COMMD4 Knockout jurkat Polyclonal Cells

COMMD4 Knockout jurkat Polyclonal Cells

Cat. No. ARG13264
 CBX3 Knockout K562 Polyclonal Cells

CBX3 Knockout K562 Polyclonal Cells

Cat. No. ARG42761
 CASP9 Knockout MES-OV Polyclonal Cells

CASP9 Knockout MES-OV Polyclonal Cells

Cat. No. ARG42555
 MAD1L1 Knockout AGS Polyclonal Cells

MAD1L1 Knockout AGS Polyclonal Cells

Cat. No. ARG3240